---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-026239"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2022-12-08T23:59:59+00:00"
generated_at: "2026-06-21T07:26:35.773073+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Arcadia creates Series A Preferred with voting rights on reverse stock split; quorum lowered to one-third

## Summary
- Declared dividend of 1/1000th share of Series A Preferred per common share; record date Dec 28, 2022, distribution Dec 29, 2022.
- Each 1/1000th of Series A Preferred carries 1,000 votes, but only on proposals for a reverse stock split and adjournment.
- Preferred shares are not transferable except with transfer of common shares; voting automatically mirrors common share vote.
- Bylaws amended to reduce stockholder meeting quorum from majority to one-third of voting power.
- Unredeemed preferred shares redeemed after meeting for $0.10 per 100 shares (subject to conditions); odd lots may receive no cash.

## SEC filing metadata
- accession: 0000950170-22-026239
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2022-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017022026239/0000950170-22-026239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017022026239/rkda-20221207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-026239
- JSON: https://secwatch.observer/filing/0000950170-22-026239.json
- Plain text: https://secwatch.observer/filing/0000950170-22-026239.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.